The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Carbimazole 20 mg Tablets

Essential-Healthcare Ltd.PA2130/001/002

Main Information

Trade NameCarbimazole 20 mg Tablets
Active SubstancesCarbimazole
Dosage FormTablet
Licence HolderEssential-Healthcare Ltd.
Licence NumberPA2130/001/002

Group Information

ATC CodeH03BB Sulfur-containing imidazole derivatives
H03BB01 carbimazole


License statusAuthorised
Licence Issued14/06/2018
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back